Commentary
Podcast
Author(s):
Dr Danish discusses barriers to using radiotherapy for the treatment of patients with metastatic lung and bone cancers; the novel capabilities of SCINTIX biology-guided technology; and how John Theurer Cancer Center plans to use this technology and help advance its role in the field of radiation oncology.
Welcome to OncLive On Air®! I’m your host today, Ashling Wahner.
OncLive On Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.
In today’s episode, we had the pleasure of speaking with Adnan F. Danish, MD, about the use of SCINTIX biology-guided radiotherapy in patients with lung and bone tumors. Dr Danish is a radiation oncologist at John Theurer Cancer Center, Hackensack University Medical Center in Hackensack, New Jersey. He is also chief of the Division of Radiation Oncology at St Joseph’s Health in Paterson, New Jersey.
On February 2, 2023, the FDA granted clearance to SCINTIX for the treatment of patients with primary or metastatic lung and bone tumors. SCINTIX also has FDA clearance for use in stereotactic body radiation therapy, intensity-modulated radiation therapy, and stereotactic radiosurgery for patients with all solid tumors.
In our exclusive interview, Dr Danish discussed current barriers to using radiotherapy for the treatment of patients with metastatic lung and bone cancers; the novel capabilities of SCINTIX technology; and how John Theurer Cancer Center plans to use this technology and help advance its role in the field of radiation oncology.
___
That’s all we have for today! Thank you for listening to this episode of OncLive On Air®. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.
For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.
OncLive® is also on social media. On Twitter, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.
If you liked today’s episode of OncLive On Air®, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!
Thanks again for listening to OncLive On Air®.
*OncLive On Air® is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.